GDRX GoodRx Holdings Inc
Price (delayed)
$4.57
Market cap
$1.75B
P/E Ratio
114.25
Dividend/share
N/A
EPS
$0.04
Enterprise value
$1.85B
GoodRx Holdings, Inc. is a holding company that provides price comparison tool for prescriptions. The Company provides GoodRx platform, which aggregates and analyzes pricing data from a number of different
Highlights
The debt is down by 24% YoY
GDRX's gross profit is up by 9% year-on-year
GoodRx Holdings's equity has decreased by 4.9% YoY but it has increased by 4.1% from the previous quarter
The quick ratio has decreased by 28% YoY
Key stats
What are the main financial stats of GDRX
Market
Valuations
Earnings
Shares outstanding
383.61M
Market cap
$1.75B
Enterprise value
$1.85B
Price to earnings (P/E)
114.25
Price to book (P/B)
2.4
Price to sales (P/S)
2.22
EV/EBIT
21.9
EV/EBITDA
11.69
EV/Sales
2.33
Revenue
$792.32M
Gross profit
$744.11M
Operating income
$65.85M
Net income
$16.39M
EBIT
$84.38M
EBITDA
$158.1M
Free cash flow
$113.55M
Per share
Balance sheet
Liquidity
EPS
$0.04
EPS diluted
$0.04
Free cash flow per share
$0.29
Book value per share
$1.9
Revenue per share
$2.05
TBVPS
$2.08
Total assets
$1.39B
Total liabilities
$663.41M
Debt
$543.39M
Equity
$724.66M
Working capital
$535.35M
Debt to equity
0.75
Current ratio
5.32
Quick ratio
4.8
Net debt/EBITDA
0.6
Margins
Efficiency
Dividend
EBITDA margin
20%
Gross margin
93.9%
Net margin
2.1%
Operating margin
8.3%
Return on assets
1.2%
Return on equity
2.4%
Return on invested capital
9.7%
Return on capital employed
6.7%
Return on sales
10.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GDRX stock price
How has the GoodRx Holdings stock price performed over time
Intraday
3.16%
1 week
0.66%
1 month
-8.23%
1 year
-32.79%
YTD
-1.72%
QTD
3.63%
Financial performance
How have GoodRx Holdings's revenue and profit performed over time
Revenue
$792.32M
Gross profit
$744.11M
Operating income
$65.85M
Net income
$16.39M
Gross margin
93.9%
Net margin
2.1%
The net margin has soared by 200% from the previous quarter
The company's operating income has surged by 124% QoQ
The operating margin has soared by 124% QoQ
GDRX's gross profit is up by 9% year-on-year
Growth
What is GoodRx Holdings's growth rate over time
Valuation
What is GoodRx Holdings stock price valuation
P/E
114.25
P/B
2.4
P/S
2.22
EV/EBIT
21.9
EV/EBITDA
11.69
EV/Sales
2.33
GDRX's P/B is 75% below its 5-year quarterly average of 9.3 and 39% below its last 4 quarters average of 3.8
GoodRx Holdings's equity has decreased by 4.9% YoY but it has increased by 4.1% from the previous quarter
The price to sales (P/S) is 79% lower than the 5-year quarterly average of 10.2 and 35% lower than the last 4 quarters average of 3.3
The revenue is up by 6% YoY
Efficiency
How efficient is GoodRx Holdings business performance
The company's return on equity has surged by 200% QoQ
The company's return on invested capital has surged by 70% QoQ
The company's return on sales has surged by 61% QoQ
Dividends
What is GDRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GDRX.
Financial health
How did GoodRx Holdings financials performed over time
GoodRx Holdings's total assets is 109% more than its total liabilities
The quick ratio has decreased by 28% YoY
The company's current ratio fell by 25% YoY and by 2.9% QoQ
The debt is 25% less than the equity
The debt is down by 24% YoY
GDRX's debt to equity is down by 19% year-on-year and by 3.8% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.